Intramedullary Melanocytoma with Multifocal Spinal Recurrence: An Uncommon Case Study - Top-Institutions - MDSpire

Intramedullary Melanocytoma with Multifocal Spinal Recurrence: An Uncommon Case Study

  • By

  • Jiri Nepozitek

  • Veronika Rottova

  • Martin Syrucek

  • Veronika Ticha

  • January 5, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    The Johns Hopkins Hospital
    The Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuropathology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuropathology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuropathology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuropathology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Neuropathology

Original Source(s)

Intramedullary Melanocytoma with Multifocal Spinal Recurrence: An Uncommon Case Study

  • by Jiri Nepozitek, Veronika Rottova, Martin Syrucek, Veronika Ticha

  • January 5, 2026

Related Content

Beyond synapses non-synaptic neural microenvironment interactions remodel circuits and drive glioma progression

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD.

Colorectal Cancer Treatment During Pregnancy

Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.